Marieann R. Brill, PhD, MBA, RAC, MLS(ASCP), is a distinguished public health and regulatory science leader with over 20 years of experience across the FDA, Department of Defense, and academic institutions. She is widely recognised for her expertise in regulatory affairs, medical device evaluation, clinical research oversight, and public health policy, with a strong focus on advancing the safety, effectiveness, and innovation of medical products.

She currently serves in senior leadership at the FDA’s Center for Devices and Radiological Health, including roles as Deputy Office Director and Acting Office Director within the Office of Orthopedic Devices, where she leads high-impact regulatory decision-making and contributes to national and global policy development for emerging technologies.

Previously, she served as Associate Director for Regulatory Affairs in the Office of Pediatric Therapeutics and held leadership roles at the Center for Tobacco Products and within military and federal health programs, overseeing regulatory submissions, clinical trials, and compliance initiatives.

Alongside her federal service, she is an Adjunct Lecturer and mentor, committed to developing future professionals in public health and regulatory science. She holds a PhD in Public Health (Epidemiology), an MBA in Healthcare Management, and maintains RAC and MLS certifications.